Search results for "From ACP Internist Weekly"
Some newer diabetes drugs may help decrease risk of COPD exacerbation
A cohort study in the United Kingdom found that chronic obstructive pulmonary disease (COPD) exacerbations were less common in patients with type 2 diabetes and COPD taking glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors versus sulfonylureas.
https://diabetes.acponline.org/archives/2022/12/09/7.htm
9 Dec 2022
GLP-1 analogues may be associated with bile duct, gallbladder disease
Current use of DPP-4 inhibitors was not associated with increased risk for bile duct and gallbladder disease versus current use of at least 2 oral antidiabetic drugs, but an increased risk was seen with use of GLP-1 analogues.
https://diabetes.acponline.org/archives/2016/08/12/7.htm
12 Aug 2016
Physicians may overtreat blood pressure, glucose in older patients with diabetes
A retrospective cohort study used data from the Department of Veterans Affairs to assess both hypertension and blood glucose medication deintensification (i.e., dosage reduction or withdrawal of a drug).
https://diabetes.acponline.org/archives/2015/11/13/7.htm
13 Nov 2015
Exercise tips for type 1 diabetes offered by consensus statement
The consensus statement advises physicians about ways to manage people with type 1 diabetes who exercise regularly, including glucose targets for safe and effective exercise and nutritional and insulin dose adjustments to protect against exercise-related glucose excursions.
https://diabetes.acponline.org/archives/2017/02/10/8.htm
10 Feb 2017
Aspirin primary prevention trial in Japan halted for lack of mortality benefit
Low-dose aspirin for primary prevention reduced nonfatal myocardial infarction, but not death from cardiovascular causes, in older Japanese patients, a recent study found.
https://diabetes.acponline.org/archives/2014/12/12/7.htm
12 Dec 2014
Once-weekly insulin had similar effects to daily insulin in type 2 diabetes, industry-funded trial finds
HbA1c levels improved by more than a point in insulin-naive patients with inadequately controlled type 2 diabetes who were randomized to a weekly 70-U dose of an investigational insulin.
https://diabetes.acponline.org/archives/2020/10/09/8.htm
9 Oct 2020
Task Force releases systematic review about diabetes screening
A systematic evidence review by the U.S. Preventive Services Task Force suggests that screening asymptomatic adults for elevated glucose levels could help delay progression to diabetes but has not been shown to improve mortality rates.
https://diabetes.acponline.org/archives/2015/06/12/6.htm
12 Jun 2015
Text messages may improve glycemic control in patients with diabetes and coronary disease
Patients in a Chinese study received six automated text messages per week with educational and motivational information on glucose monitoring, blood pressure control, medication adherence, physical activity, and lifestyle.
https://diabetes.acponline.org/archives/2019/09/13/9.htm
13 Sep 2019
No clear-cut choice among once-weekly GLP-1 receptor agonists
All once-weekly GLP-1 receptor agonists reduced HbA1c and fasting plasma glucose levels, and either no differences or clinically marginal differences were found among the drugs for blood pressure, blood lipid levels, and C-reactive protein levels, according to the systematic review and network meta-analysis.
https://diabetes.acponline.org/archives/2015/12/11/6.htm
11 Dec 2015
Patients on tramadol more likely to be hospitalized for hypoglycemia
Patients who began taking tramadol were significantly more likely to be hospitalized for hypoglycemia than those prescribed codeine, a recent study found.
https://diabetes.acponline.org/archives/2015/01/09/6.htm
9 Jan 2015